Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 1/20 | 0.34 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27088868 | 0.69 | PSMB1 (0.47) | PSMB1L3MBTL1TOP2BPOLBNPSR1 | |
| SCHEMBL31119353 | 0.69 | PSMB1 (0.31) | PSMB1POLBNPSR1TSHRPSMB5 | |
| SCHEMBL16654263 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL29142213 | 0.68 | PSMB1 (0.46) | PSMB1L3MBTL1TOP2BPOLBNPSR1 | |
| SCHEMBL8349900 | 0.68 | TSHR (0.48) | MAPK1TSHRALDH1A1HTT | |
| SCHEMBL8770339 | 0.67 | L3MBTL1 (0.40) | L3MBTL1KDM4ETSHRALDH1A1LMNA | |
| SCHEMBL11408828 | 0.67 | NTRK1 (0.52) | CDC25AL3MBTL1TOP2BNPSR1KDM4E | |
| SCHEMBL3530061 | 0.65 | CYP1A2 (0.45) | NPSR1TSHRALDH1A1GAALMNA | |
| SCHEMBL1724271 | 0.65 | PSMB1 (0.50) | PSMB1L3MBTL1POLBNPSR1TSHR | |
| SCHEMBL22836716 | 0.65 | PSMB1 (0.38) | PSMB1POLBNPSR1KDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11529299-B2 | Hair care compositions comprising a 2-pyridinol-n-oxide material and an iron chelator | THE PROCTER & GAMBLE COMPANY (US) | 2022-12-20 | — | — | US | disclosed |
| EP-3644951-A1 | HAIR CARE COMPOSITIONS COMPRISING A 2-PYRIDINOL-N-OXIDE MATERIAL AND AN IRON CHELATOR | The Procter and Gamble Company (US) | 2020-05-06 | — | — | EP | disclosed |
| WO-2019006233-A1 | HAIR CARE COMPOSITIONS COMPRISING A 2-PYRIDINOL-N-OXIDE MATERIAL AND AN IRON CHELATOR | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-03 | — | — | WO | disclosed |
| US-20190000735-A1 | HAIR CARE COMPOSITIONS COMPRISING A 2-PYRIDINOL-N-OXIDE MATERIAL AND AN IRON CHELATOR | THE PROCTER & GAMBLE COMPANY | 2019-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11529299-B2 | Hair care compositions comprising a 2-pyridinol-n-oxide material and an iron chelator | PLOD1, DPM1, PNPO | CDC25A 523/4885PSMB1 196/4885L3MBTL1 3840/4885 |
| US-20190000735-A1 | HAIR CARE COMPOSITIONS COMPRISING A 2-PYRIDINOL-N-OXIDE MATERIAL AND AN IRON CHELATOR | PLOD1, DPM1, PNPO | CDC25A 523/4885PSMB1 196/4885L3MBTL1 3840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.